Related Experiment Video
Updated: May 26, 2025

06:59
Transcription Start Site Mapping Using Super-low Input Carrier-CAGE
Published on: June 26, 2019
12.0K
A Reverse Transcription Nucleic-Acid-Based Barcoding System for In Vivo Measurement of Lipid Nanoparticle mRNA
Kevin C Wang1, Tiana L Young1, Jingan Chen2
1Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario M5S 3M2, Canada.
ACS Bio & Med Chem Au
|February 24, 2025
Summary
We developed Quantitative Analysis of Reverse Transcribed Barcodes (QuART), a new method to screen lipid nanoparticle (LNP) delivery systems for mRNA therapeutics. This nucleic acid-based system enables efficient in vitro and in vivo functional LNP screening.
Area of Science:
- Biotechnology
- Molecular Biology
- Drug Delivery Systems
Background:
- Lipid nanoparticles (LNPs) are crucial for mRNA therapeutics delivery, as seen in COVID-19 vaccines.
- Current LNP screening methods hinder the rapid development of novel mRNA therapeutics.
- Efficient and scalable screening is essential for advancing LNP technology.
Purpose of the Study:
- To develop a novel nucleic acid-based system for assessing functional mRNA delivery by lipid nanoparticles (LNPs).
- To enable high-throughput screening of LNP formulations for improved mRNA therapeutic development.
Main Methods:
- Developed Quantitative Analysis of Reverse Transcribed Barcodes (QuART), a system linking mRNA delivery to a cDNA barcode readout.
- Utilized a bacterial retron reverse transcription system for functional mRNA delivery measurement.
- Validated QuART for assessing LNP delivery efficiency in vitro (cell culture) and in vivo (mice).
Main Results:
- QuART successfully measured functional mRNA delivery in both cell culture and live mice.
- The system demonstrated its capability to identify effective LNP delivery.
- Demonstrated the potential for multiplexing QuART for enhanced screening capacity.
Conclusions:
- QuART provides a novel and effective method for evaluating LNP-mediated mRNA delivery.
- This system can accelerate the discovery and optimization of LNP formulations for mRNA therapeutics.
- QuART facilitates high-throughput screening, addressing a key bottleneck in LNP development.
More Related Videos
Related Concept Videos
Next-generation Sequencing
87.0K
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
87.0K
RNA-seq
9.8K
RNA sequencing, or RNA-Seq, is a high-throughput sequencing technology used to study the transcriptome of a cell. Transcriptomics helps to interpret the functional elements of a genome and identify the molecular constituents of an organism. Additionally, it also helps in understanding the development of an organism and the occurrence of diseases.
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
9.8K
Sanger Sequencing
752.3K
DNA sequencing is a fundamental technique that is routinely used in the biological sciences. This method can be applied to a range of questions at different scales - from the sequencing of a cloned DNA fragment or the study of a mutation in a gene up to whole-genome sequencing. However, despite the widespread use of sequencing today, it was not until 1977 that Fredrick Sanger and his collaborators developed the chain-termination method to decode DNA sequences. It relies on the separation of a...
752.3K
RACE - Rapid Amplification of cDNA Ends
6.3K
Rapid Amplification of cDNA Ends, or RACE, is one of the most effective methods to obtain a full-length cDNA from an mRNA sequence between a known internal region to the unknown sequence at the 5’ or 3’ end. The unknown region is cloned in the cDNA by a gene-specific primer that binds the known end, and a hybrid primer that attaches a predefined anchor sequence to the unknown end of the cDNA. The sequence in between is amplified by PCR with an anchor primer and a gene-specific...
6.3K
Real Time RT-PCR
56.7K
Real-time reverse transcription-polymerase chain reaction, or Real-time RT-PCR, is an analytical tool used to determine the expression level of target genes. The method involves converting mRNA to complementary DNA with the help of an enzyme known as reverse transcriptase, followed by the PCR amplification of the cDNA. These two processes can be performed simultaneously in a single tube or separately as a two-step reaction.
The real-time quantification of the number of amplified products is...
The real-time quantification of the number of amplified products is...
56.7K

